Arnold M Baskies
CIK 1683567 · last filed 2026-07-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$492.1K
Companies
3
Total Filings
30
Lifetime Open-Market Net
$492.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIX | Director | 141,000 | $3.49 | $492.1K | $484.2K | 24 | 2026-07-29 |
| Baudax Bio, Inc. (BXRX) Delisted | Director | 1,050 | $0.02 | $23 | $8.2K | 4 | 2022-06-17 |
| Anixa Biosciences Inc (ITUS) Delisted | Director | — | — | — | $0 | 2 | 2017-09-08 |
Recent Filings · Page 2 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-17 | Baudax Bio, Inc. (BXRX) Delisted | Grant (A) | +39,473 | $0 | EDGAR |
| 2022-03-11 | ANIX | Grant (A) | — | $0 | EDGAR |
| 2021-07-27 | ANIX | Buy (P) | +19,000 | $82.3K | EDGAR |
| 2021-07-16 | ANIX | Buy (P) | +20,000 | $78.0K | EDGAR |
| 2021-06-02 | ANIX | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | Baudax Bio, Inc. (BXRX) Delisted | Buy (P) | +10,000 | $8.2K | EDGAR |
| 2021-04-20 | ANIX | Buy (P) | +10,000 | $39.1K | EDGAR |
| 2021-04-08 | Baudax Bio, Inc. (BXRX) Delisted | Grant (A) | +56,452 | $0 | EDGAR |
| 2021-03-25 | ANIX | Buy (P) | +10,000 | $48.0K | EDGAR |
| 2020-08-21 | Baudax Bio, Inc. (BXRX) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.